COVID-19 UPDATE: We are open! Our team is working and offering consultations via phone, e-mail, and video conferencing.

Robert Cowan Photo

Robert Cowan

  • Profile
  • Credentials
  • Associations

Robert oversees and coordinates the firm’s successful, award-winning trial and appellate briefing team, as well as takes the “lead pen” on many of the firm’s most critical written court submissions. He also argues many of those issues in court. His current practice areas include Fair Labor Standards Act cases (overtime and wage litigation recovery), pharmaceutical products liability litigation, state government Medicaid fraud recovery and asbestos exposure liability cases.

Noteworthy successes on the firm’s behalf include:

  • $124 million consumer protection trial victory against Risperdal-maker Janssen Pharmaceuticals affirmed by South Carolina Supreme Court; drug company’s appeal denied by United States Supreme Court (attorneys’ fees & expenses: $23,101,269);
  • $15.5 million consumer protection settlement in favor of the Commonwealth of Kentucky against Risperdal-maker Janssen Pharmaceuticals (attorneys’ fees & expenses: $2,244,646.85);
  • $7.75 million settlement in favor of the State of Arkansas in deceptive trade practices action against Ortho-McNeil-Janssen and Johnson & Johnson (attorneys’ fees & expenses $2 million);
  • Rob was the lead briefing attorney for co-lead counsel in In re Seroquel Products Liability Litigation, MDL 1769, in the United States District Court for the Middle District of Florida; 
  • Pursued to successful resolution deceptive trade practice cases against major drug manufacturers on behalf the states of Arkansas, Mississippi, New Mexico, and South Carolina;
  • Repeatedly defeated defendants’ delay and forum-shopping tactics by successfully convincing federal courts to transfer (remand) cases back to state courts where they were originally filed;
  • Defeated summary judgment motion on federal preemption grounds filed by a pharmaceutical manufacturer in the largest docket of antipsychotic drug injury cases pending in the country;
  • Defeated pharmaceutical defendants’ motion to disqualify firm in Medicaid fraud recovery lawsuit in Pennsylvania, including two disqualification attempts in the trial court and on appeal to the Pennsylvania Supreme Court; and secured denial of a writ of certiorari in the Louisiana Supreme Court, as well as denial of supervisory writ application in the Louisiana Court of Appeal, against drug maker seeking to invade the privacy of thousands of Louisiana Medicaid patients through unnecessary disclosure of their personal medical records.

Before joining the firm in 2007, Rob practiced on the defense side of the bar for six years with an emphasis on trial and appellate briefing on behalf of large multinational corporations, state agencies and local governments, industry groups, and individuals.

While a defense lawyer, Rob drafted successful briefing to the United States Court of Appeals for the Fifth Circuit in high-profile litigation brought by the original Marlboro Man’s family against Philip Morris, represented a noteworthy former Merrill Lynch analyst in the Enron shareholder litigation, successfully briefed First Amendment and wrongful termination issues relating to the City of Houston’s controversial police chase policy in a Fifth Circuit appeal on the city’s behalf, as well as assisted in defending the world’s wealthiest man and his related business interests in two multimillion-dollar tortious interference lawsuits filed in Texas.

  • JD, Magna Cum Laude South Texas College of Law - Graduate School 2001
  • B.A. University of Houston - University 1990
  • State Bar of Texas Nov 1, 2001
  • The Missouri Bar Jul 1, 2016